eshmuno resins
65 Results
Búsqueda avanzada
Mostrar
-
-
Eshmuno® IEX Chromatography Family of Resins | Biopharmaceutical Manufacturing | Merck
The Eshmuno® family of resins: A unique family of ion exchangers designed for highly productive downstream purification of monoclonal antibodies. -
Ready-to-Use PAB Cleaning Solution for Chromatography Resins | Biopharmaceutical Manufacturing | Merck
Our ready-to-use, rapidly sanitizing PAB solution is specifically designed for the cleaning and storage of our ProSep® and Eshmuno® Protein A affinity chromatography media. -
Resinas Eshmuno® P anti-A y Eshmuno® P anti-B | Merck
Cantidades vestigiales de isoaglutininas anti-A y anti-B en las inmunoglobulinas (Ig) plasmoderivadas se han asociado con un mayor riesgo de hemólisis en los pacientes, una complicación grave y a veces letal. -
Eshmuno® Q Chromatography Resin | Biopharmaceutical Manufacturing | Merck
Eshmuno® Q resin is a strong anion exchanger for the purification of biomolecules and plasma derived products. -
Eshmuno® CPS Resin | Biopharmaceutical Manufacturing | Merck
Eshmuno® CPS resin combines high dynamic binding capacity and separation efficiency in downstream purification of recombinant protein feed streams at elevated salt concentrations. -
Eshmuno® S Chromatography Resin | Biopharmaceutical Manufacturing | Merck
Eshmuno® S is a strong cation exchange resin designed for fast, efficient purification of antibodies in direct capture and post-protein A steps. -
Event | A3P BioProduction International Congress | Merck
Next Generation Bioprocessing is considered to be any technology, expendable, or system which significantly changes the existing monoclonal antibody manufacturing template to deliver higher productivity, increased manufacturing flexibility, increased speed, and reduced risk. Meet our experts to get insights and perspectives on the on-going paradigm shift and evolution towards Next Generation Bioprocessing occurring in today's and tomorrow's biopharmaceutical landscape. -
Emprove® Chromatography | Merck
Emprove® Dossiers for Purification in Biomanufacturing Process High performing resins meet regulatory excellence Any component and raw material used at a later stage of the biomanufacturing process is considered a risk, as it could add a bioburden to the final drug product. While being essential, chromatography steps are often a challenge as they are highly process specific and might be present from early to late downstream. Therefore, information is crucial for manufacturers when selecting chromatography methods and products. -
Explore What's Next with Merck
If you're involved with drug development or manufacturing, you're in a unique position. Every day, you are creating possibilities to improve human health. While others wonder what's to come, you are building it. For decades, our customers have counted on MilliporeSigma's commitment to quality, safety and reliability to help them pave the way to the science of tomorrow. Now you can leverage MilliporeSigma's technological innovations to shape the future of pharmaceutical processing.